INSIDE TRACK CONFERENCE
MOLECULAR DIAGNOSTICS, GENOMICS AND EPIGENETICS IN CLINICAL ONCOLOGY
25-26 November 2016 Rome, Italy
Chairs:
M.S. Aapro, CH J. Gligorov, FR
WWW.ESO.NET
#MOLDIAconf16
Follow us on
FOREWORD
The main common feature of cancer cells is their ability to escape to homeostatic regulation mechanisms of living. In a sense giving them immortality, causing in the absence of treatment the death of the
organism, which is their origin. The exponential knowledge of the biology of cancer and the phenomenal capacity of synthesis of new treatments and diagnostic tools have opened up the prospect of a precision medicine in oncology that requires regular and frequent updating of our
knowledge.
This knowledge concerns both the intrinsic prognosis of the disease, as the prediction value of therapeutic approaches that in fact becomes increasingly “personalized”. This conference, organized for several years, aims to take stock of current and future tools that help us optimize the care of patients with cancer.
LEARNING OBJECTIVES
• Update the knowledge of the implications for practice and clinical research (tools to be used, tools still in research, areas where no tools are yet available)
• Understanding epigenetics and genomics research and their impact on cancer prognosis and therapy response (prediction)
CME ACCREDITATION AND CERTIFICATES
Participants will be entitled to receive a certificate of attendance at the close of the Masterclass by completing the online evaluation
questionnaire.
The event has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the
European Union of Medical Specialists (UEMS). The evaluation of the event has been performed by the Accreditation Council of Oncology in Europe (ACOE) that acknowledged the quality of the scientific programme and its educational value. The event is designated for a maximum of 9 European CME credits (ECMEC). Through an agreement between UEMS and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.
Furthermore, for Italian participants, a maximum of 10 ECM credits have been granted by Commissione Nazionale per la Formazione Continua.
More information can be obtained from the organizing secretariat.
FACULTY (as of September)
M.S. Aapro
IMO Clinique de Genolier, CH D. Arnold
CUF Hospitals Cancer Center, Lisbon, PT L. Crinò
University of Perugia, Perugia, IT G. Curigliano
European Institute of Oncology, Milan, IT R. Danesi
University of Pisa, Pisa, IT L. Del Mastro
Istituto Nazionale per la Ricerca sul Cancro, Genoa, IT V. Dieras
Institut Curie, Paris, FR E. Felip
Vall d'Hebron University Hospital, Barcelona, ES J. Gligorov
Hopitaux Universitaires Paris Est Tenon, Paris, FR N. Mottet
Hopital Nord, Saint Etienne, FR N. Normanno
INT-Fondazione Pascale, Naples, IT F. Penault-Llorca
Centre Jean Perrin, Clermon-Ferrand, FR J. Remon
Institut Gustave Roussy, Le Plessis Robinson, FR J. Robert
Universitè Bordeaux Segalen, Bordeux, FR E. Rouleau
Institut Gustave Roussy, Villejuif, FR C. Sotiriu
Université Libre de Bruxelles, Brussels, BE A. Stathis
Oncology Institute of Southern Switzerland, Bellinzona, CH D. Tilki
University Hospital Hamburg-Eppendorf - Martini Klinik, Hamburg, DE G. Viale
European Institute of Oncology, Milan, IT
PRELIMINARY PROGRAMME
FRIDAY, 25 NOVEMBER
9:45 Welcome and introduction M.S. Aapro, CH and J. Gligorov, FR INTRODUCTORY SESSION
10:00 Understanding drivers of cancer cell development 10:20 Discussion
C. Sotiriu, BE
10:30 Understanding next generation sequencing 10:50 Discussion
R. Rouleau, FR
11:00 Understanding liquid biopsies 11:20 Discussion
R. Danesi, IT
11:30 Understanding pharmacogenetics in cancer treatment and clinical trials
11:50 Discussion J. Robert, FR
12:00 Round table and discussion Chairs and faculty
12:30 Lunch
WHERE DO WE STAND ON LUNG CANCER?
13:30 Lung cancer as a model for the development of personalized medicine: What should you ask from your pathologist in order to apply specific treatments
13:50 Discussion E. Felip, ES
14:00 Future developments in medical lung cancer therapy 14:20 Discussion
L. Crinò, IT
14:30 Clinical case discussion J. Remon, FR
15:00 Coffee break
WHERE DO WE STAND IN PROSTATE CANCER?
15:30 Genomic tools in prostate cancer 15:50 Discussion
D. Tilki, DE
16:00 How to decide the medical treatment of prostate cancer?
16:20 Discussion based on a clinical case N. Mottet, FR
16:30 Genomics: An essential aspect for haemato-oncologists 16:50 Discussion
A. Stathis, CH
17:00 Day’s closure
M. Aapro, CH and J. Gligorov, FR
SATURDAY, 26 NOVEMBER
WHERE DO WE STAND IN COLORECTAL CANCER?
8:30 Genomic tools in colorectal cancer 8:50 Discussion
N. Normanno, IT
9:00 How does the clinician use these data to best treat colon and rectal cancer?
9:20 Discussion based on a clinical case D. Arnold, DE
10:00 Coffee break
WHERE DO WE STAND IN BREAST CANCER?
10:00 Pathological characterisation of breast cancer: Bridges between molecular and pathological definitions (triple negative, liminal, lobular…)
10:20 Discussion G. Viale, IT
10:30 Molecular characterisation of breast cancer: When is it needed?
Is lobular an unrecognized special case?
10:50 Discussion
F. Penault-Llorca, FR
11:00 Neoadjuvant/adjuvant therapy: How to manage early triple- negative tumours with and without BRCA mutations
11:20 Discussion based on a clinical case L. Del Mastro, IT
11:30 Treatment of HER-2 positive disease in the (neo-) adjuvant settings: What alternatives?
11:50 Discussion based on a clinical case V. Dieras, FR
12:00 What is or is not special about invasive lobular tumour adjuvant treatment
12:20 Discussion based on a clinical case G. Curigliano, IT
12:30 Close
M. Aapro, CH and J. Gligorov, FR 12:45 Lunch and departures
REGISTRATION
Register online at www.eso.net.
Registration grants participantion in all sessions, a copy of the Programme Book, coffee breaks and lunches as indicated in the programme.
All rates are quoted in Euro and include VAT.
GENERAL INFORMATION
Early (by 28 August) Late (by 23 October) On-site (from 24 October)
Registration fee EUR 240 EUR 360 EUR 480
Club ESO Members EUR 220 EUR 360 EUR 480
CANCELLATION OF REGISTRATION OR REPLACEMENT
Cancellation should be notified to ESO in writing. In case of cancellation without replacement, the fee less handling charges of EUR 100 will be refunded after the event, provided that the cancellation is recived by ESO before 16 October.
Replacements will be possible till 16 October.
CONFIRMATION OF REGISTRATION
Registration will be confirmed preferably by e-mail, by fax or by mail.
MEDIA REGISTRATION
The Conference is open to representatives of print and electronic media.
Registration is free of charge to journalists who are in possession of a valid, recognised press card. Freelance journalists must present a commissioning letter on headed paper from a recognised news organisation or publication.
Representatives of advertising, marketing and public relations companies are not eligible for free media registration.
A copy of the Press Card or the commissioning letter should be sent, together with the media registration form, to [email protected].
ORGANISING SECRETARIAT European School of Oncology (ESO) Bellinzona Office
Piazza Indipendenza, 2 6500 Bellinzona - Switzerland Fax: +41 91 820 09 53 - www.eso.net
VENUE
Radisson Blu ES. Hotel Via Turati, 171
Rome, Italy
Tel: +39 06 444 841- www.radissonblu.com/eshotel-rome Programme and organisation
Luis Carvalho - [email protected] Tel: +41 91 820 09 58
Programme and registrations Laura Richetti - [email protected] Tel: +41 91 820 09 51
GENERAL INFORMATION
BADGE
The badge is the only official evidence of registration and should be worn at all times during the event. Loss of badge causes loss of registration.
INSURANCE
The organisers bear no responsibility for untoward events in relation to the participation in the Conference. Participants are advised to take out their own personal and travel insurance.
TRAVEL GRANTS
Travel grants were made available on a competitive basis. The application deadline is passed (28 August).
OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.
HOTEL ACCOMMODATION
The following are recommended hotels located close to the conference venue.
Hotel Category Walking distance to the venue
Radisson Blu Hotel
www.radissonblu.com/eshotel-rom Conference venue
Royal Santina Hotel
www.hotelroyalsantina.com 12 minutes
Una Hotel
www.unahotels.it/en/una_hotel_roma/roma_hotels.htm 7 minutes Hotel Caracciolo
www.hotelcaracciolo.com 5 minutes
Amalfi Hotel
www.hotelamalfiroma.it 10 minutes
More information is available at www.eso.net.
ACKNOWLEDGEMENTS
ESO wishes to extend its appreciation to Genomic Health for having granted its support to the conference through an unrestricted grant.
MOLECULAR DIAGNOSTICS, GENOMICS AND EPIGENETICS IN CLINICAL ONCOLOGY 25-26 NOVEMBER 2016 - Rome, Italy
Please fill in this form in BLOCK LETTERS and send by the deadline to:
European School of Oncology (ESO) - Piazza Indipendenza, 2, 6500 Bellinzona - Switzerland, Fax: +41 91 820 09 53 - E mail: [email protected]
ONLINE REGISTRATION IS AVAILABLE AT: WWW.ESO.NET PARTICIPANT'S DETAILS
Dr. Prof. Mrs. Mr.
Surname Name
Institute Department Street
Zip Code Town Country
Phone Fax Mobile
Date of birth Birth date (town and country)
Profession
Specialisation Main field
VAT number (compulsory for self-employed persons) Fiscal code (Italian residents only)
If your invoice details are different to those above, please complete the following section:
Invoice contact details Address
Phone email
VAT number (compulsory for self-employed persons) Fiscal Code (Italian residents only)
REGISTRATION
All rates are quoted in Euro and include VAT.
PAYMENT DETAILS:
The registration is processed when payment accompanies the form (credit card details or copy of bank transfer) Visa/Mastercard Card Number / / /
Expire date / CV2 code
Holder’s name (in CAPITAL LETTERS): and signature
BANK TRANSFER with no cost to the beneficiary (please provide a copy of the bank transfer):
Bank: Banca Popolare di Milano, Agenzia 24 - Milan, Italy Account holder: European School of Oncology
Number: No. 16333
IBAN: IT96G0558401624 0000000 16333 - BIC: BPMIITMMXXX Reference: "Molecolar Diagnostics" + your name
I authorize the European School of Oncology to use my personal data according to what is specified in Article 13 DLGS 196, available at www.eso.net or on request at fax number +39 02 8546 4545.
Signature Date
REGISTRATION FORM
Early (by 28 August) Late (by 23 October) On-site (from 24 October)
Registration fee EUR 240 EUR 360 EUR 480
Club ESO Members EUR 220 EUR 360 EUR 480
